These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 17338653)

  • 1. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based practice: management of glottic cancer.
    Hartl DM
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1143-61. PubMed ID: 22980690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary management of laryngeal carcinoma.
    Mendenhall WM; Mancuso AA; Hinerman RW; Malyapa RS; Werning JW; Amdur RJ; Villaret DB
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S12-4. PubMed ID: 17848278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larynx preservation.
    Lefebvre JL
    Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
    Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
    J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for carcinoma of the supraglottis.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Otolaryngol Clin North Am; 1997 Feb; 30(1):145-61. PubMed ID: 8995142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ preservation for cancer of the larynx: current indications and future directions.
    Gilbert J; Forastiere AA
    Semin Radiat Oncol; 2004 Apr; 14(2):167-77. PubMed ID: 15095262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
    Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
    Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection.
    Hinerman RW; Mendenhall WM; Amdur RJ; Stringer SP; Villaret DB; Robbins KT
    Head Neck; 2002 May; 24(5):456-67. PubMed ID: 12001076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laryngeal epidermoid carcinoma in a young adult without risk factors: a case report].
    M'barek B; Gargouri W; Maalej M
    Tunis Med; 2005 Aug; 83(8):503-4. PubMed ID: 16238282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.